[go: up one dir, main page]

AR043621A1 - Vacuna de vibrio cholerae inactivada en tabletas - Google Patents

Vacuna de vibrio cholerae inactivada en tabletas

Info

Publication number
AR043621A1
AR043621A1 ARP040100865A ARP040100865A AR043621A1 AR 043621 A1 AR043621 A1 AR 043621A1 AR P040100865 A ARP040100865 A AR P040100865A AR P040100865 A ARP040100865 A AR P040100865A AR 043621 A1 AR043621 A1 AR 043621A1
Authority
AR
Argentina
Prior art keywords
vibrio cholerae
vaccine
inactivated
tablets
vaccines
Prior art date
Application number
ARP040100865A
Other languages
English (en)
Inventor
Perez Tania Balmaseda
Suarez Caridad Torres
Marrero Barbara Cedre
Imia Luis Garcia
Quinoy Jose Luis Perez
Coronel Arturo Talavera
Lopez Gemma Ano
Fernandez Jorge Luis Castano
Hernandez Evangelina Urribarri
Navarro Yadira Pino
Sanchez Hilda Maria Garcia
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of AR043621A1 publication Critical patent/AR043621A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente se relaciona en el campo de las vacunas, específicamente con las vacunas de aplicación oral contra el cólera. El objetivo técnico que persigue es obtener una formulación en tabletas de vacunas de células enteras inactivadas de Vibrio cholerae. Se describe la fórmulación del producto vacunal.
ARP040100865A 2003-03-20 2004-03-16 Vacuna de vibrio cholerae inactivada en tabletas AR043621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030061A CU23334A1 (es) 2003-03-20 2003-03-20 Vacuna de vibrio cholerae inactivada en tabletas

Publications (1)

Publication Number Publication Date
AR043621A1 true AR043621A1 (es) 2005-08-03

Family

ID=40203015

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100865A AR043621A1 (es) 2003-03-20 2004-03-16 Vacuna de vibrio cholerae inactivada en tabletas

Country Status (13)

Country Link
US (1) US20060246094A1 (es)
EP (1) EP1614427A1 (es)
JP (1) JP2006520332A (es)
KR (1) KR20050109978A (es)
CN (1) CN1791426A (es)
AR (1) AR043621A1 (es)
BR (1) BRPI0408409A (es)
CA (1) CA2519225A1 (es)
CU (1) CU23334A1 (es)
EC (1) ECSP055997A (es)
PE (1) PE20041064A1 (es)
WO (1) WO2004082711A1 (es)
ZA (1) ZA200507576B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN02860A (es) * 2009-09-16 2015-06-19 Gotovax Ab
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US6203799B1 (en) * 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit

Also Published As

Publication number Publication date
ECSP055997A (es) 2006-01-27
CN1791426A (zh) 2006-06-21
US20060246094A1 (en) 2006-11-02
CA2519225A1 (en) 2004-09-30
KR20050109978A (ko) 2005-11-22
EP1614427A1 (en) 2006-01-11
PE20041064A1 (es) 2005-03-02
CU23334A1 (es) 2008-12-24
WO2004082711A1 (es) 2004-09-30
JP2006520332A (ja) 2006-09-07
BRPI0408409A (pt) 2006-03-21
ZA200507576B (en) 2007-01-31

Similar Documents

Publication Publication Date Title
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
MX2012005365A (es) Formulaciones de tableta de liberacion inmediata.
MX2010001401A (es) Productos medicos mejorados, revestidos con preparaciones farmaceuticas, la produccion de los mismos y el uso de los mismos.
UY31350A1 (es) (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos
ECSP10010295A (es) Formulacion de anticuerpo
ECSP066826A (es) Inhibidores de integrasa de vih
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
AR069508A1 (es) Derivados de quinolina 057; un proceso para su preparacion; una composicion farmaceutica; la preparacion de esta y el uso del compuesto para preparar un medicamento
UA99645C2 (ru) Гель, имеющий противовоспалительное и противоаллергическое действие
AR054188A1 (es) Aminas ciclicas con actividad inhibitoria del factor de coagulacion xa, metodos para su sintesis, intermediarios del proceso de obtencion de las mismas y su elaboracion, composiciones farmaceuticas que las contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades del a
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
ECSP088569A (es) Nuevos derivados de furopirimidina acíclicos sustituidos y uso de los mismos para el tratamiento de enfermedades cardiovasculares
NO20084478L (no) Konjugerte lipidderivater
CR20150266A (es) Formulaciones de liberación modificada para oprozomib
CL2010000281A1 (es) Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion.
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
GT200800235A (es) Formulacion de medicamento liquida
AR043621A1 (es) Vacuna de vibrio cholerae inactivada en tabletas
WO2008152334A3 (fr) Nouveaux dérivés d'acide 3-phenyl acrylique activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques
CL2023000764A1 (es) Formas farmacéuticas multipartículas que comprenden deutetrabenazina
ATE534382T1 (de) Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
RU2009107155A (ru) Антиоксидантное лекарственное средство на основе спиртовых отходов
AR077451A1 (es) Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40

Legal Events

Date Code Title Description
FA Abandonment or withdrawal